Colony stimulating factor-2 receptor alpha (CSF2RA) and interleukin-3 receptor alpha (IL3RA), two genes from the chromosome Xp and Yp pseudoautosomal region (PAR), have been suggested as candidate genes for short stature in Turner syndrome. We report three girls with X;Y translocation (46,X,der(X)t(X;Y) (p22; ql1)) initially detected by amniocentesis.
Bone age radiograph showed a skeletal age of 30 months at a chronological age of 23 months. Thyroid function studies were normal. Growth factor profile showed a normal insulin-like growth factor 1 (IGF-1) of 42 ng/ml (normal range 11-206) and low insulin-like growth factor binding protein 3 (IGFBP3) of 0.9mg/l (normal range 1.4-3). Growth hormone (GH) deficiency was confirmed by an abnormal response to a clonidine stimulation test. Gonadal hormone profile showed luteinising hormone (LH) of <2 mIU/ ml, FSH of 3.0 mIU/ml, and oestradiol of <20 pg/ml, all within the normal range. Her breast tissue development was considered to be premature thelarche. At 26 months of age she was started on growth hormone therapy at a dose of 0.3 mg/kg/week. Her growth velocity accelerated to 12.1 cm per year during the first year of therapy which is 2 SD above the normal rate and an expected response for a growth hormone deficient child. At the age of 31 years there was once again concern about further breast development. A luteinising hormone releasing hormone (LHRH) stimulation study done at this stage showed normal LHRH response, thus ruling out true precocious puberty. Her growth velocity during the second year of GH treatment averaged 7.6 cm per year. Her most recent height at the age of 4 years was on the 30th centile.
CASE 2
Amniocentesis was done on a G2, P1 white female for reasons of advanced maternal age and a previous child with trisomy 21. Ultrasound examination before amniocentesis had shown a twin pregnancy with female fetuses. Amniotic fluid cell karyotypes were identical and abnormal with both showing 46,X, der(X)t(X;Y)(p22.3;ql 1.21). Normal karyotypes were found for the parents indicating that the X;Y translocation was a de novo rearrangement. Further cytogenetic and molecular studies showed that the p arm, centromere, and the proximal q arm of the Y chromosome were not present on the derivative X chromosome. Ultrasound examination at 30.3 weeks' gestation suggested that the limbs of the fetuses were at the short end of the normal range with the humerus and femur on the 3rd centile, radius and ulna on the 10th centile, and tibia on the 25th centile.
The monochorionic twins were born without complications at 36 weeks' gestation. Twin 1 had a birth weight of 2300 g (25th centile), length of 43.2 cm (5th centile), and head circumference of 32 cm (25th centile). Twin 2 had a birth weight of 2360 g (30th centile), a length of 45.7 cm (25th centile), and a head circumference of 32.3 cm (40th centile). There were no congenital anomalies noted. Laboratory studies ruled out amino acid and organic acidurias, mucopolysacchariduria, galactosaemia, thyroid disease, biotinidase deficiency, PKU, and G6PD deficiency. Linear growth failure was first appreciated at their 18 month well child examination. Their weight and head circumference were noted to be on the 50th centile while their height was 75 cm (<5th centile, 50th centile for age 1 year). Both twins were also noted to have dolichocephaly, a narrow flat face, downward slanting palpebral fissures, epicanthic folds, and a slightly flat nasal bridge. When last seen at 2 years of age, twin 1 was 81.5 cm and twin 2 was 81 cm tall (<5th centile, 50th centile for age 12 years). Both had weights on the 50th centile. Their development has been completely normal with regard to gross motor, fine motor, and language development. IGF-1 and IGFBP3 levels were within the normal range for age and sex for both twins, ruling out GH deficiency. Molecular cytogenetic studies were carried out on only one of the twins. CASE 
3
A 37 year old G4, P2 white female was seen following the detection of a fetal chromosome abnormality during the 21 st week ofpregnancy. Amniocentesis was done for advanced maternal age. Fetal karyotype was reported as 46,X, der(X)t(X;Y)(p22.3;ql 1). From her first marriage she had a 16 year old son and a 13 year 8Joseph, Cantu, Pai, Willi, Papenhausen, Weiss old daughter both in good health. With her current husband who is 25 years old, she had one miscarriage before this pregnancy. Further family history was unremarkable. As chromosome analysis was normal for both parents, the fetal karyotypic anomaly was considered to be a de novo event. FISH studies of amniocytes confirmed the absence of the SRY gene and Y centromeric sequences on the derivative X chromosome. The parents were counselled regarding normal female sexual development and absent risk for gonadoblastoma in the offspring. Her prenatal course was unremarkable and the pregnancy ended at term in the birth of a normal female weighing 3400 g (60th centile) and 53.3 cm long (75th centile). She had an uneventful neonatal period and has remained healthy with normal psychomotor development. Her length, which was on the 75th centile at birth, dropped to the 50th centile by 7 months, and to the 5th centile at 22 months. Serum IGF-1 and IGFBP3 levels were normal at the age of 24 months providing no evidence of GH deficiency. A total of at least 20 metaphase spreads were scored for each probe used in each case. A normal male control was used to show and compare the normal signals of the CSF2RA and IL3RA loci on the PARs of both Xp and Yp termini. A positive signal was considered as a fluorescent signal present at the expected sites on both chromatids of a metaphase chromosome. If positive signals were present on both the normal X chromosome and on the derivative X chromosome, the sample was considered non-deleted for the probe used.
Methods

Results
CYTOGENETICS
An abnormal karyotype of 46,X,der(X)t(X; Y)(p22;ql 1) at a band resolution of 450 to 650 was confirmed in all three girls. Routine GTG banded preparations showed the der(X) chromosome, which by banding pattern and mor- 1 and fig 3. Both CSF2RA and IL3RA loci were found to be deleted on the derivative X chromosomes of all the three cases, while their normal X chromosomes showed positive signals. The STS locus was found to be deleted on the derivative X chromosomes of cases 1 and 3 while it was present on the der(X) chromosome of case 2. The STS locus was present on the normal X chromosome in all three cases. The most proximal Kallmann locus was present on the normal and derivative X chromosomes of all three patients. The control male sample showed positive signals for both CSF2RA and IL3RA loci on both the X and Y chromosomes. The presence of a putative growth gene residing in the terminal portion of Xp, the deletion of which decreases the adult height by an average of 12 cm, was suggested by the findings of a family study in which 13 adult females with 46,X,del(X)(p23) in two pedigrees were significantly shorter than their nine 46,XX adult female relatives.2 Molecular studies of patients with partial monosomy at the pseudoautosomal region have suggested that a locus affecting height maps to a 1.5 Mb long segment in terminal Xp within the PAR, distal to DXYS85 and proximal to DXYS87 (fig 1).3 The 2.6Mb of DNA in the Xp-Yp PAR constitutes 1.6% of the human X chromosome and 3-5% of the Y8 (fig 3) . CSF2RA and IL3RA are the only two known functioning genes from the distal 1.5Mb of the Xp-Yp PAR, the region thought to harbour the height controlling locus/loci. 
